In: Cardiovascular Research, 2010, vol. 87, no. 1, p. 166-176
|
In: American Journal of Hypertension, 1999, vol. 12, no. 12, p. 1201-1208
|
In: Pflügers Archiv, 2003, vol. 447, no. 2, p. 254-258
|
In: European Heart Journal, 2010, vol. 31, no. 1, p. 67-76
|
In: Internal and Emergency Medicine, 2014, vol. 9, no. 4, p. 411-417
|
In: Metabolism - Clinical and Experimental, 2010, vol. 59, no. 1, p. 25-32
Telmisartan is an angiotensin II receptor blocker with peroxisome proliferator–activated receptor–γ agonistic properties. Telmisartan prevents weight gain and decreases food intake in models of obesity and in glitazone-treated rodents. This study further investigates the influence of telmisartan and pioglitazone and their association on weight gain and body composition by examining...
|
In: Journal of Thrombosis and Thrombolysis, 2013, vol. 36, no. 4, p. 475-483
|
In: Circulation, 2004, vol. 110, p. 3708-3714
Background— Arginase competes with endothelial nitric oxide synthase (eNOS) for the substrate L-arginine and decreases NO production. This study investigated regulatory mechanisms of arginase activity in endothelial cells and its role in atherosclerosis. Methods and Results— In human endothelial cells isolated from umbilical veins, thrombin concentration- and time-dependently stimulated...
|
In: European Heart Journal, 2015, vol. 36, no. 10, p. 591-597
|